Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2000

01-06-2000 | SHORT COMMUNICATIONS

Treatment of catheter-induced thrombotic superior vena cava syndrome: a single institution's experience

Authors: Manuel Morales, Valentí Comas, Mercedes Trujillo, Javier Dorta

Published in: Supportive Care in Cancer | Issue 4/2000

Login to get access
Metadata
Title
Treatment of catheter-induced thrombotic superior vena cava syndrome: a single institution's experience
Authors
Manuel Morales
Valentí Comas
Mercedes Trujillo
Javier Dorta
Publication date
01-06-2000
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2000
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s005200000118

Other articles of this Issue 4/2000

Supportive Care in Cancer 4/2000 Go to the issue

ORIGINAL ARTICLE

Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan

ORIGINAL ARTICLE

Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost–benefit analysis

REVIEW ARTICLE

Ceftriaxone versus β-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis

ORIGINAL ARTICLE

Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine / oncology and haematology

REVIEW ARTICLE

New tools in diagnosing catheter-related infections

ORIGINAL ARTICLE

The impact of home palliative care on symptoms in advanced cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits